Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease

Background Screening for intracranial aneurysms (IAs) in patients with risk factors of IA is recommended. However, genetic risk factors of IA in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear, and genotype–phenotype relationships in IAs in patients with ADPKD have...

Full description

Bibliographic Details
Main Authors: Hiroshi Kataoka, Hiroyuki Akagawa, Yusuke Ushio, Masayo Sato, Shun Manabe, Shiho Makabe, Keiko Kawachi, Taro Akihisa, Naomi Iwasa, Rie Yoshida, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Stroke: Vascular and Interventional Neurology
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/SVIN.121.000203
_version_ 1811154676407599104
author Hiroshi Kataoka
Hiroyuki Akagawa
Yusuke Ushio
Masayo Sato
Shun Manabe
Shiho Makabe
Keiko Kawachi
Taro Akihisa
Naomi Iwasa
Rie Yoshida
Ken Tsuchiya
Kosaku Nitta
Toshio Mochizuki
author_facet Hiroshi Kataoka
Hiroyuki Akagawa
Yusuke Ushio
Masayo Sato
Shun Manabe
Shiho Makabe
Keiko Kawachi
Taro Akihisa
Naomi Iwasa
Rie Yoshida
Ken Tsuchiya
Kosaku Nitta
Toshio Mochizuki
author_sort Hiroshi Kataoka
collection DOAJ
description Background Screening for intracranial aneurysms (IAs) in patients with risk factors of IA is recommended. However, genetic risk factors of IA in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear, and genotype–phenotype relationships in IAs in patients with ADPKD have not been clarified. Therefore, we aimed to clarify the associations between germline mutations and IA formation in patients with ADPKD. Methods A total of 135 patients with ADPKD who were evaluated for ADPKD mutations were examined for IA formation in this single‐center observational study. Results The incidence of de novo IA formation was 1.3% per patient‐year. Age at IA diagnosis was younger in patients with frameshift (median, 36 years; P=0.003) and splicing mutations (median, 43 years; P=0.046) than in patients with substitutions (median, 63 years). Multivariable analyses showed that IA was associated with female sex (odds ratio [OR], 3.32 [95% CI, 1.10–10.01]; P=0.03), a family history of IA or subarachnoid hemorrhage (OR, 3.05 [95% CI, 1.07–8.71]; P=0.04), estimated glomerular filtration rate (OR, 0.69 [95% CI, 0.54–0.87]; P=0.002), and splicing mutations (OR, 9.30 [95% CI, 1.71–50.44]; P=0.01). Splicing mutations showed a significant association with IA formation even in subcohorts with minimal risk factors for IA, such as age <50 years (OR, 19.52 [95% CI, 3.22–118.51]; P=0.001), nonhypertension (OR, 49.28 [95% CI, 3.60–673.98]; P=0.004), and nonsmoking behavior (OR, 27.79 [95% CI, 3.49–221.21]; P=0.002). Conversely, substitutions showed significant associations with IA formation in subcohorts such as age ≥50 years (OR, 8.66; 95% CI, 1.43–52.51; P=0.02) and chronic kidney disease stages 4 and 5 (OR, 10.70 [95% CI, 1.05–108.75]; P=0.045). Conclusions Genetic analyses in patients with ADPKD could contribute to IA screening and could be useful for evaluating the prognosis, including complications. IA screening should be recommended for patients with ADPKD who have splicing and frameshift mutations and for older patients or patients with advanced ADPKD who have substitutions.
first_indexed 2024-04-10T04:21:08Z
format Article
id doaj.art-d5ed69fea6b14f22aa695deb4044646a
institution Directory Open Access Journal
issn 2694-5746
language English
last_indexed 2024-04-10T04:21:08Z
publishDate 2022-09-01
publisher Wiley
record_format Article
series Stroke: Vascular and Interventional Neurology
spelling doaj.art-d5ed69fea6b14f22aa695deb4044646a2023-03-11T07:58:11ZengWileyStroke: Vascular and Interventional Neurology2694-57462022-09-012510.1161/SVIN.121.000203Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney DiseaseHiroshi Kataoka0Hiroyuki Akagawa1Yusuke Ushio2Masayo Sato3Shun Manabe4Shiho Makabe5Keiko Kawachi6Taro Akihisa7Naomi Iwasa8Rie Yoshida9Ken Tsuchiya10Kosaku Nitta11Toshio Mochizuki12Department of Nephrology Tokyo Women's Medical University Tokyo JapanTokyo Women's Medical University Institute for Integrated Medical Sciences Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Blood Purification Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanDepartment of Nephrology Tokyo Women's Medical University Tokyo JapanBackground Screening for intracranial aneurysms (IAs) in patients with risk factors of IA is recommended. However, genetic risk factors of IA in patients with autosomal dominant polycystic kidney disease (ADPKD) remain unclear, and genotype–phenotype relationships in IAs in patients with ADPKD have not been clarified. Therefore, we aimed to clarify the associations between germline mutations and IA formation in patients with ADPKD. Methods A total of 135 patients with ADPKD who were evaluated for ADPKD mutations were examined for IA formation in this single‐center observational study. Results The incidence of de novo IA formation was 1.3% per patient‐year. Age at IA diagnosis was younger in patients with frameshift (median, 36 years; P=0.003) and splicing mutations (median, 43 years; P=0.046) than in patients with substitutions (median, 63 years). Multivariable analyses showed that IA was associated with female sex (odds ratio [OR], 3.32 [95% CI, 1.10–10.01]; P=0.03), a family history of IA or subarachnoid hemorrhage (OR, 3.05 [95% CI, 1.07–8.71]; P=0.04), estimated glomerular filtration rate (OR, 0.69 [95% CI, 0.54–0.87]; P=0.002), and splicing mutations (OR, 9.30 [95% CI, 1.71–50.44]; P=0.01). Splicing mutations showed a significant association with IA formation even in subcohorts with minimal risk factors for IA, such as age <50 years (OR, 19.52 [95% CI, 3.22–118.51]; P=0.001), nonhypertension (OR, 49.28 [95% CI, 3.60–673.98]; P=0.004), and nonsmoking behavior (OR, 27.79 [95% CI, 3.49–221.21]; P=0.002). Conversely, substitutions showed significant associations with IA formation in subcohorts such as age ≥50 years (OR, 8.66; 95% CI, 1.43–52.51; P=0.02) and chronic kidney disease stages 4 and 5 (OR, 10.70 [95% CI, 1.05–108.75]; P=0.045). Conclusions Genetic analyses in patients with ADPKD could contribute to IA screening and could be useful for evaluating the prognosis, including complications. IA screening should be recommended for patients with ADPKD who have splicing and frameshift mutations and for older patients or patients with advanced ADPKD who have substitutions.https://www.ahajournals.org/doi/10.1161/SVIN.121.000203autosomal dominant polycystic kidney diseaseintracranial aneurysmsmutationssplicing mutationsubstitutionuniversal screening
spellingShingle Hiroshi Kataoka
Hiroyuki Akagawa
Yusuke Ushio
Masayo Sato
Shun Manabe
Shiho Makabe
Keiko Kawachi
Taro Akihisa
Naomi Iwasa
Rie Yoshida
Ken Tsuchiya
Kosaku Nitta
Toshio Mochizuki
Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
Stroke: Vascular and Interventional Neurology
autosomal dominant polycystic kidney disease
intracranial aneurysms
mutations
splicing mutation
substitution
universal screening
title Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
title_full Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
title_fullStr Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
title_full_unstemmed Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
title_short Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease
title_sort mutation type and intracranial aneurysm formation in autosomal dominant polycystic kidney disease
topic autosomal dominant polycystic kidney disease
intracranial aneurysms
mutations
splicing mutation
substitution
universal screening
url https://www.ahajournals.org/doi/10.1161/SVIN.121.000203
work_keys_str_mv AT hiroshikataoka mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT hiroyukiakagawa mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT yusukeushio mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT masayosato mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT shunmanabe mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT shihomakabe mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT keikokawachi mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT taroakihisa mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT naomiiwasa mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT rieyoshida mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT kentsuchiya mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT kosakunitta mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease
AT toshiomochizuki mutationtypeandintracranialaneurysmformationinautosomaldominantpolycystickidneydisease